Research
Metabolic adaptation
Semaglutide and tirzepatide achieve weight-loss outcomes comparable to bariatric surgery.
These medications may be considered as alternatives to surgical weight loss options.
StrongSupportsmedium confidence
Agents such as semaglutide and tirzepatide are setting new standards, achieving weight-loss outcomes comparable to bariatric surgery.
Why this rating
The claim is based on emerging standards in antiobesity treatment.
Source
Pharmacologic options for the treatment of overweight and obesity
Maria Daniela Hurtado Andrade · Menopause The Journal of The North American Menopause Society · 2025
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →